Showing results (391-400 of 415) with videos related to

Sort By:
Pageof 42
JCO Precision Oncology|February 1, 2022
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR AlterationsDavid M Hyman, Ben Tran, Luis Paz-Ares, et al.
Cancer Research Communications|September 15, 2023
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other TumorsGlenn J Hanna, Anastasios Stathis, Elena Lopez-Miranda, et al.
Science Translational Medicine|April 17, 2015
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancerAna Bosch, Zhiqiang Li, Anna Bergamaschi, et al.
Annals of the Rheumatic Diseases|April 26, 2025
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 updateLinda Rüegg, Andrea Pluma, Sabrina Hamroun, et al.
Journal of Personalized Medicine|June 2, 2021
A System Pharmacology Multi-Omics Approach toward Uncontrolled Pediatric AsthmaMahmoud I Abdel-Aziz, Anne H Neerincx, Susanne J H Vijverberg, et al.
Quarterly Journal of the Royal Meteorological Society. Royal Meteorological Society (Great Britain)|December 3, 2019
Current state of the global operational aerosol multi-model ensemble: An update from the International Cooperative for Aerosol Prediction (ICAP)Peng Xian, Jeffrey S Reid, Edward J Hyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion StudyLucia Nogova, Lecia V Sequist, Jose Manuel Perez Garcia, et al.
Nature|May 31, 2023
Engineered tRNAs suppress nonsense mutations in cells and in vivoSuki Albers, Elizabeth C Allen, Nikhil Bharti, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 11, 2021
Genome-wide association studies of exacerbations in children using long-acting beta2-agonistsElise M A Slob, Levi B Richards, Susanne J H Vijverberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer PatientsRichard D Baird, Annelot G J van Rossum, Mafalda Oliveira, et al.
Pageof 42